Medline, Inc. MDLN Income Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| —— | $25.51B+9.8% | ||
| $12M+20.0% | $10M+42.9% | ||
| —— | $18.53B+6.8% | ||
| —— | $6.98B+18.5% | ||
| $80M+19.4% | $67M+11.7% | ||
| —— | $4.11B+6.2% | ||
| —— | $61M-21.8% | ||
| $106M+17.8% | $90M+34.3% | ||
| —— | $977M+2.7% | ||
| —— | $63M+688% | ||
| $0— | —— | ||
| —— | $4.83B+4.2% | ||
| —— | $4.83B+4.2% | ||
| —— | $2.15B+71.7% | ||
| —— | $1.14B-5.7% | ||
| —— | $280M+18.1% | ||
| —— | -$900M+8.7% | ||
| -$58M-81.3% | -$32M— | ||
| —— | $1.25B+372% | ||
| —— | $46M+53.3% | ||
| —— | $1.16B+397% | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | -$864M+11.5% | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | $61M-16.4% | ||
| —— | $57M-28.7% | ||
| —— | $685M+3.5% | ||
| $0-100% | $25M-72.2% | ||
| —— | —— | ||
| —— | —— | ||
| $58M+16.0% | $50M+100% | ||
| —— | -$1.34B-213% | ||
| $34M— | —— | ||
| —— | $170M0.0% | ||
| —— | $1.02B+539% | ||
| —— | $0— | ||
| —— | $1.02B+539% | ||
| $24M+300% | $6M— | ||
| $83M+43.1% | $58M+26.1% | ||
| $4M-33.3% | $6M-14.3% | ||
| —— | 3— | ||
| $4M— | $0— | ||
| -$24M0.0% | -$24M-4.3% | ||
| —— | -$24M-4.3% | ||
| $0— | $0— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| $0.03-5.8% | $0.03— | ||
| —— | —— | ||
| $49M+14.0% | $43M+16.2% | ||
| $307M+5.1% | $292M+1.0% | ||
| —— | $2M-50.0% | ||
| —— | —— | ||
| $0.21— | —— | ||
| —— | $1M0.0% | ||
| —— | —— | ||
| —— | —— | ||
| $2M-94.1% | $34M+21.4% | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| $0— | —— | ||
| $41M— | $0— | ||
| —— | $7M+164% | ||
| —— | $10M+433% | ||
| —— | $538M— | ||
| —— | $8.07B— | ||
| $10M+300% | -$5M— | ||
| $4M— | —— | ||
| $929M-2.4% | $952M+6,247% | ||
| $319M+8.5% | $294M+18.1% | ||
| $12M— | —— | ||
| $3M— | —— | ||
| -$1M— | —— | ||
| $2M— | —— | ||
| $160M— | —— | ||
| -$19M+91.0% | -$211M-402% | ||
| $262M0.0% | $262M+376% | ||
| —— | —— | ||
| $1M— | $0-100% | ||
| $4M-33.3% | $6M-14.3% | ||
| —— | $12M— | ||
| —— | $2M+100% | ||
| $62M-38.6% | $101M+94.2% | ||
| —— | $106M-22.1% | ||
| —— | $256M+67.3% | ||
| —— | $62M+155% | ||
| —— | $545M+223% | ||
| —— | -$46M-150% | ||
| —— | -$88M-267% | ||
| —— | —— | ||
| —— | —— | ||
| —— | $1.02B-9.2% | ||
| $83M+56.6% | $53M-13.1% | ||
| $129M+19.4% | $108M+33.3% | ||
| $141M+19.5% | $118M+34.1% | ||
| $17M+13.3% | $15M-11.8% | ||
| —— | —— | ||
| —— | -$1.61B-745% | ||
| —— | -$1.49B-379% | ||
| —— | $1.77B+5.0% | ||
| —— | —— | ||
| —— | —— | ||
| —— | $1.2B+413% | ||
| $0— | $0-100% | ||
| —— | $61M+29.8% | ||
| —— | —— | ||
| 3— | —— | ||
| 20.0% | 2— | ||
| $15M+15.4% | $13M-13.3% | ||
| $109M+29.8% | $84M+50.0% | ||
| —— | -$12M-114% | ||
| —— | $77M+63.8% | ||
| —— | -$88M+23.5% | ||
| —— | -$88M+23.5% | ||
| —— | $165M+1.9% | ||
| $16M— | —— | ||
| —— | -$89M-307% | ||
| —— | -$177M-139% | ||
| $8M— | $0-100% | ||
| —— | $22M+340% | ||
| —— | -$43M-4,400% | ||
| —— | -$37M+65.1% | ||
| —— | $58M+45.0% | ||
| —— | —— | ||
| —— | $1.5B+1,217% | ||
| —— | $9M— | ||
| —— | $57M+54.1% | ||
| —— | $53M-24.3% | ||
| $33M+230% | $10M0.0% | ||
| $0-100% | $3M-72.7% | ||
| $1.97B— | $0— | ||
| —— | $20M— | ||
| $0-100% | $12M— | ||
| —— | $0— | ||
| —— | $1.13B+6,938% | ||
| —— | $354M+28.7% | ||
| —— | —— | ||
| —— | $274M+29.2% | ||
| —— | —— | ||
| $7.05B— | $0— | ||
| —— | $166M— | ||
| —— | $63M+688% | ||
| —— | $165M+1.9% | ||
| —— | $0— | ||
| —— | $0— | ||
| —— | $166M— | ||
| $11.66B-27.1% | $16B+20,673% | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | $61M-21.8% | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| $4M+33.3% | $3M+50.0% | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | $18M— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | $17M— | ||
| —— | —— | ||
| —— | $37M— | ||
| —— | $2M— | ||
| -$1M-200% | $1M— | ||
| $31M+24.0% | $25M+31.6% | ||
| $2M0.0% | $2M0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Medline, Inc. 's revenue?
- Medline, Inc. (MDLN) generated $26.7B in revenue over the trailing twelve months, up 9.8% year over year.
- Is Medline, Inc. profitable?
- Medline, Inc. reported $841.8M in net income over the trailing twelve months, a 4.6% net margin.
- What are Medline, Inc. 's profit margins?
- Gross margin is 27.4% and operating margin is 8.5%, with a 4.6% net margin.
- Where does Medline, Inc. 's income statement data come from?
- Every line is extracted from Medline, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
